Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
1
Mins
8th July 2022
Predicting Type 2 Diabetes Remission in Patients of Gastric Bypass
Blood ceramide levels could help predict whether patients with Type 2 diabetes who undergo gastric bypass surgery will experience remission…
8th July 2022
The Value of Evidence-Based Medicine
In this week’s episode, Jonathan is joined by Uwe Gudat, Chief Medical Officer, Aretaeus Sàrl, Geneva, Switzerland.
10
Mins
8th July 2022
Editor’s Pick: Impact of COVID-19 on Diagnostic Delay in Rare Disease
Rare diseases are individually rare but collectively common, with a combined prevalence of 3.5–5.9%. A common feature of many diseases is a substantial delay in patients receiving a correct diagnosis; this protracted path to diagnosis is termed ‘the diagnostic odyssey’.
7th July 2022
IME Rheumatology Webinar | Key Insights from EULAR 2022 - An Interdisciplinary Expert Roundtable Discussion
Watch our roundtable discussion to gain a deeper understanding of emerging data from the EULAR 2022 congress.
New AZ study reveals extent of CKD worldwide
Chronic kidney disease is present in one in 10 adults, according to a recent study by AstraZeneca. Read the article for more details.
8
Mins
7th July 2022
Novel Targeted Compression for the Prevention of Implantable Cardioverter Defibrillator or Pacemaker Pocket Complications: Strategies to Avoid Haematoma and Minimise Risk of Infection
Implantable cardioverter defibrillators (ICDs), pacemakers, and cardiac resynchronisation therapy (CRT) devices are placed in a pocket…
July 2022
EMJ Cardiology 10 [Supplement 2] 2022
EMJ had the pleasure of interviewing leading specialists within the field of cardiology and electrophysiology, Bruno Schwagten, ZNA Middelheim, Antwerp, Belgium, and Yurii Deminskyi…
Cardiovascular catalyst launched by Novartis
A new CVD initiative has been launched by Novartis UK to drive innovation and improve patient access to prevention solutions.
Big pharma vs biotech and the future of marketing
Helena and Marc are joined by Michele Manto, CCO, Galapagos, and Robert Grimm, Digital Marketing and Transformation Manager, Novo Nordisk.
1
Mins
5th July 2022
EMJ ranked as one of Britain's fastest-growing private companies
EMJ, Europe’s leading digital health communications company, has been ranked in the 2022 edition of The Sunday Times 100.
←
1
2
3
…
252
253
254
255
256
257
258
…
897
898
899
→
![EMJ Cardiology 10 [Supplement 2] 2022 Feature Image](https://www.emjreviews.com/wp-content/uploads/2022/07/EMJ-Cardiology-10-Supplement-2-2022-Feature-Image-1-940x563.jpg)
